Skip to content

INTERVAL Study: To Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased

A Randomised Trial to Determine Whether the Interval Between Blood Donations in England Can be Safely and Acceptably Decreased

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01610635
Acronym
INTERVAL
Enrollment
50000
Registered
2012-06-04
Start date
2012-06-30
Completion date
2016-12-31
Last updated
2015-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Donation

Keywords

RCT, blood donation frequency, quality of life, iron deficiency

Brief summary

It is hypothesised that the number of donations made by English blood donors will be greater with reduced vs. standard inter-donation intervals. The null hypothesis is that there will be no difference in donations between treatment groups; this may arise if reduced inter-donation intervals result in a greater number of donation deferrals (due to low haemoglobin) and/or an unacceptable burden to donors.

Detailed description

50,000 blood donors will be recruited from permanent blood donation centres across England to compare different intervals between blood donations to try to find the optimum interval for which it is safe for different donors to give blood. The study will look at whether intervals should be tailored by age, gender, genetic profile, and other characteristics. Study findings should help to improve the well-being of future blood donors in England and enhance the country's blood supplies.

Interventions

OTHERReduced versus standard intervals between blood donations

Over a period of two years participants will be invited to give blood either at usual donation intervals or more frequently. Men will be invited to donate every 12, 10 or 8 weeks and women every 16, 14 or 12 weeks.

Sponsors

National Health Service, Blood and Transplant
CollaboratorUNKNOWN
University of Oxford
CollaboratorOTHER
University of Cambridge
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Aged 18 years or older and fulfilling all normal criteria for blood donation 2. Willing to be assigned to any of the study intervention groups 3. Registered at one of the permanent donation clinics at the time of enrolment

Exclusion criteria

* As the aim of the study is to be almost paper-less, it will involve remote web-based data collection. Hence, participants who do not have internet access and/or are not willing to provide an email address for study correspondence will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Total blood collected after two years24 monthsExpressed in units (470ml) per person per year

Secondary

MeasureTime frameDescription
Markers of iron status24 monthsSerum ferritin and reticulocyte haemoglobin
Cognitive ability24 monthsReasoning, attention and memory
Levels of physical activity24 months
Number of donation deferrals24 monthsTemporary rejection of donors due to low haemoglobin and other factors
Donor attitudes, beliefs and values24 months
Donor quality of life24 monthsMeasured using the SF-36 health survey
Cost effectiveness24 months

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026